Gehan Devendra Selected Research

Heparin (Liquaemin)

10/2007

No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gehan Devendra Research Topics

Disease

2	COVID-19 08/2023 - 01/2023
2	Fibrosis (Cirrhosis) 08/2023 - 01/2023
1	Lung Neoplasms (Lung Cancer) 05/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Sepsis (Septicemia) 02/2021
1	Septic Shock (Toxic Shock Syndrome) 02/2021
1	Lung Injury 01/2012
1	Pulmonary Hypertension 01/2012
1	Thrombocytopenia (Thrombopenia) 10/2007
1	Thrombosis (Thrombus) 10/2007
1	Pulmonary Embolism 10/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2007
1	Lung Diseases (Lung Disease) 01/2002

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 08/2023 - 01/2012
2	LigandsIBA 08/2023 - 01/2023
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023 - 01/2023
1	Mitochondrial RNAIBA 05/2023
1	Biomarkers (Surrogate Marker)IBA 05/2023
1	Small Cytoplasmic RNAIBA 01/2023
1	Milrinone (Primacor)FDA LinkGeneric 02/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 02/2021
1	Dobutamine FDA LinkGeneric 02/2021
1	Methylprednisolone FDA LinkGeneric 01/2012
1	SteroidsIBA 01/2012
1	Heparin (Liquaemin)FDA LinkGeneric 10/2007
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2007
1	Surface-Active Agents (Surfactants)IBA 01/2002

Therapy/Procedure

1	Endarterectomy (Thromboendarterectomy) 01/2012